The Centers for Medicare & Medicaid Services (CMS) continues to expand value-based payment initiatives, and the Ambulatory Specialty Model (ASM) represents a significant shift for outpatient specialty care. Unlike voluntary programs, ASM introduces mandatory participation and ties reimbursement directly to quality and cost performance. For organizations that may be affected, understanding how this model works is essential to managing financial risk and maintaining compliance.
ASM initially focuses on specialists treating Medicare beneficiaries with heart failure and low back pain. Eligible clinicians in selected geographic regions will be required to participate beginning in 2027, with payment adjustments applied across all Medicare Part B claims.
- What Is the Ambulatory Specialty Model (ASM) and Who Should Participate?
- Key Takeaways
- Understanding the Ambulatory Specialty Model
- Core Objectives of the ASM
- Key Differences from Previous Models
- Mandatory Participation and Duration
- Identifying Eligible Participants
- Specialty Cohorts: Heart Failure and Low Back Pain
- Minimum Episode Volume Requirements
- Geographic Selection Process
- Performance Measurement and Scoring
- Focus on Quality and Cost Metrics
- Role of Improvement Activities and Interoperability
- Peer-to-Peer Performance Comparisons
- Financial Implications for Participants
- Potential for Positive and Negative Payment Adjustments
- Understanding Downside Risk Exposure
- Operationalizing the Ambulatory Specialty Model
- Emphasis on Care Coordination and Collaboration
- Leveraging Technology for Data Sharing
- Individual Clinician Reporting Requirements
- What This Means for You
- Key Takeaways
- ASM is a mandatory CMS payment model starting in 2027
- Applies to specialists treating heart failure or low back pain
- Eligibility depends on specialty, episode volume, and geography
- Performance is measured through peer-based quality and cost comparisons
- Participants are exempt from MIPS, but face higher upside and downside risk
Understanding the Ambulatory Specialty Model
The Ambulatory Specialty Model is designed to shift specialty reimbursement from volume-based payment to value-driven accountability. Rather than focusing on individual services, ASM evaluates defined episodes of care to assess quality and cost efficiency. This structure encourages specialists to take a broader view of patient management.
CMS selected this approach to improve outcomes for high-impact conditions while reducing unnecessary spending. By narrowing the focus to specific specialties and conditions, CMS can more accurately measure performance and outcomes.
Core Objectives of the ASM
ASM is built around several closely related goals that reinforce CMS’s broader value-based care strategy:
- Improve clinical outcomes for Medicare beneficiaries
- Reduce unwarranted variation in specialty care costs
- Encourage care coordination across providers
- Align specialist incentives with overall episode performance
Together, these objectives emphasize accountability and coordinated care rather than isolated service delivery.
Key Differences from Previous Models
While ASM builds on earlier CMS programs, it introduces structural differences that significantly affect participation and performance evaluation. The model prioritizes comparative accountability and reduces flexibility in measure selection.
Key differences include:
- Mandatory participation for eligible clinicians
- Peer-to-peer performance comparisons instead of fixed benchmarks
- Primary emphasis on quality and cost
- Improvement Activities and Promoting Interoperability provide no buffer
These changes reflect CMS’s move toward more direct and transparent performance measurement.
Mandatory Participation and Duration
Once selected, clinicians must participate in ASM for the full five-year model duration beginning January 1, 2027. Even if your practice patterns change, participation does not end early.
This long-term commitment underscores the importance of early preparation. Organizations that proactively assess performance trends and operational readiness will be better equipped to manage risk over time.
Related: How the Latest CMS Model Affects Your eCQM Strategy
Identifying Eligible Participants
CMS determines ASM participation using a defined set of criteria rather than an application process. Eligibility is determined through the intersection of specialty focus, patient volume, and geographic location. Understanding these factors can help organizations anticipate inclusion.
Specialty Cohorts: Heart Failure and Low Back Pain
The initial ASM cohorts are limited to specialists treating heart failure and low back pain. These conditions were selected due to their prevalence, complexity, and cost impact within Medicare. Focusing on specific cohorts allows CMS to test the model more effectively.
Specialists should review CMS episode definitions carefully to determine whether their services fall within scope.
Minimum Episode Volume Requirements
To ensure reliable performance measurement, CMS requires participants to meet minimum episode volume thresholds. These thresholds ensure that performance data reflects consistent clinical activity.
Organizations should assess:
- Historical Medicare claims volume
- Frequency of qualifying episodes
- Alignment with CMS-defined episode criteria
This analysis can help practices anticipate participation and prepare accordingly.
Geographic Selection Process
CMS will select approximately 25 percent of eligible regions nationwide to participate in ASM. This approach allows CMS to evaluate the model across diverse healthcare markets. Practices located in selected regions will be notified directly by CMS and required to comply with program requirements.
Related: Understanding the Latest CMS Final Rule and How It Impacts You
Performance Measurement and Scoring
Performance under ASM is measured using a standardized, comparative framework. CMS requires all participants to report the same measures, enabling direct peer comparisons. This structure reinforces accountability and consistency.
Focus on Quality and Cost Metrics
Quality and Cost each account for 50 percent of the total performance score. These categories are closely linked and evaluated together to reflect overall care value.
Quality measures may assess:
- Evidence-based medication use
- Appropriate imaging utilization
- Screening and follow-up care
Cost measures evaluate:
- Total Medicare spending per episode
- Resource utilization compared to regional medians
Strong performance requires balance across both categories.
Role of Improvement Activities and Promoting Interoperability
Improvement Activities and Promoting Interoperability influence performance through penalties rather than bonuses. Participants must complete required activities focused on care coordination and data exchange.
Key expectations include:
- Supporting patient transitions of care
- Coordinating with primary care providers
- Using certified EHR technology for data sharing
Failure to meet these requirements can negatively impact overall scores.
Peer-to-Peer Performance Comparisons
ASM relies on direct comparison among clinicians within the same specialty and region. Performance scores are calculated using a logistic function that emphasizes differences near the median.
This means:
- Small performance gaps can have meaningful financial impact
- Success depends on outperforming peers, not just meeting static thresholds
- Continuous performance monitoring is essential
Related: MIPS and EHR Integration: A Guide for Clinicians
Financial Implications for Participants
ASM introduces significant financial risk and opportunity. Payment adjustments apply to all Medicare Part B claims, making performance management a priority.
Potential for Positive and Negative Payment Adjustments
High-performing clinicians may receive positive payment adjustments, while lower performers face reductions. Adjustment limits may reach up to 9 percent initially and increase over time to 12 percent.
This structure reinforces CMS’s intent to reward efficiency and quality while holding underperformance accountable.
Understanding Downside Risk Exposure
By the final year of the model, participants may face downside risk of up to 12 percent on Medicare Part B payments. This level of exposure exceeds many prior CMS programs.
Organizations should proactively:
- Monitor performance trends
- Address quality or cost outliers early
- Strengthen care coordination efforts
Operationalizing the Ambulatory Specialty Model
Operational readiness is essential for success under ASM. CMS designed the model to promote collaboration, transparency, and data-driven decision-making.
Emphasis on Care Coordination and Collaboration
Care coordination is a core expectation under ASM. Participants must work closely with primary care providers and other specialists to manage patient care effectively.
Key focus areas include:
- Clear communication across care teams
- Defined roles and responsibilities
- Shared accountability for outcomes
Leveraging Technology for Data Sharing
Technology supports both compliance and care improvement. Certified EHR technology enables timely data exchange and informed decision-making.
Practices should evaluate:
- Interoperability capabilities
- Data sharing workflows
- Reporting and analytics tools
Individual Clinician Reporting Requirements
Although performance is assessed at the cohort level, reporting occurs at the individual clinician level. Participants are responsible for accurate and timely submission of required data.
Clear workflows and reporting support are essential to maintaining compliance.
What This Means for You
The Ambulatory Specialty Model represents a meaningful shift in how CMS reimburses specialty care. For affected clinicians, participation will be mandatory and financially impactful. While the model introduces increased accountability, it also creates opportunities for organizations that deliver high-quality, efficient care.
Preparing now; by understanding eligibility, strengthening care coordination, and leveraging data, can help organizations navigate ASM with confidence. As CMS continues to advance value-based care, proactive planning will remain critical.
